Lumen Bioscience wins historic $1.5M Wilkes Center Climate Prize

by admin | Sep 22, 2023 | Press Release

Lumen Bioscience is the inaugural winner of the $1.5 million Wilkes Center Climate Prize at the University of Utah. The Seattle-based biotech company beat 77 international teams with their proposal to drastically reduce methane emissions from dairy and beef cattle...

Cow farts are bad for Earth, but cow burps are worse. New plan could help cows belch less.

by admin | Sep 22, 2023 | Press Release

Belching – not flatulence – is the major cause of methane produced by the world’s cows and a Seattle-based company has just won $1.5 million to test a product to make cows burp less. Both ends of a cow produce methane, but 97% of all the methane gas from a cow is...

2023 Wilkes Center Climate Prize Winner: Lumen Bioscience

by admin | Sep 22, 2023 | Press Release

Watch here

Investigational C diff Antibody Takes Novel Mechanism of Action Approach

by admin | Jul 14, 2023 | Press Release

Listen here

Lumen Bioscience Receives Fast Track Designation from U.S. FDA for LMN-201

by admin | May 17, 2023 | Press Release

— Orally delivered biologic drug for treatment and prevention of C. difficile infection — LMN-201 to start pivotal trials in 2023 Seattle, WA, May 17, 2023 – Lumen Bioscience—a clinical-stage biotechnology company developing biologic drugs for highly prevalent...

Lumen Bioscience Awarded $8.1 million from U.S. Department of Defense to Develop Fast-Acting, Intranasal Countermeasure Against Respiratory Viruses

by admin | May 10, 2023 | Press Release

Seattle, WA, May 11, 2023 – Lumen Bioscience, “Lumen,” a clinical-stage biotechnology company developing biologic drugs for highly prevalent diseases, today announced a new $8.1 million project funded by the U.S. Department of Defense (DOD) to develop and test a...